TYPE: Prescription
BRAND: Larig
ACTIVE INGREDIENT: Lamotrigine
STRENGTH & PACK SIZE & GMS CODES:
25 mg Dispersible Tablets x 56 ~ 30622
50 mg Dispersible Tablets x 56 ~ 30641
100 mg Dispersible Tablets x 56 ~ 30664
200 mg Dispersible Tablets x 56 ~ 30692
INDICATION:
Epilepsy
Adults and adolescents aged 13 years and above
- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.
- Seizures associated with Lennox-Gastaut syndrome; Lamotrigine is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.
Children and adolescents aged 2 to 12 years
- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.
- Monotherapy of typical absence seizures.
Bipolar disorder
Adults aged 18 years and above
- Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.
Lamotrigine is not indicated for the acute treatment of manic or depressive episodes.
Larig 25mg SPC and Patient Information Leaflet here
Larig 50mg SPC and Patient Information Leaflet here
